Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 29 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE COUROUBLE from Schaarbeek, company number BE0828815213, closed financial year 2025 with a result of € -41,185 after tax. For that financial year PHARMACIE COUROUBLE recorded a gross margin of € -30,010 and equity of € -14,421. Compared with financial year 2024, the result moved from € 6,682 to € -41,185. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ -14,421
▼ € 41,185 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -41,185
▼ still € 6,682 profit in 2024
Profit after tax over the fiscal year.
€ 3,801
▼ 84% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -34,421.
People and assets in 2025
€ 26,922
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 22,063
▼ 24% vs 2024
€ 7,255 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 102,642
▲ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,473
▲ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -10,563 | € 5,466 | € 13,292 | € -30,010 | ▼ € 43,303 |
| Profit after taxes | € -13,037 | € 3,524 | € 6,682 | € -41,185 | ▼ € 47,867 |
| Equity | € 16,558 | € 20,082 | € 26,764 | € -14,421 | ▼ € 41,185 |
| Total debts | € 121,865 | € 112,039 | € 136,060 | € 144,093 | ▲ 6% |
| Cash | € 23,904 | € 15,980 | € 23,797 | € 3,801 | ▼ 84% |
| Retained profit | € -3,442 | € 82 | € 6,764 | € -34,421 | ▼ € 41,185 |
| Bank debt | € 9,377 | € 5,596 | € 28,997 | € 22,063 | ▼ 24% |
| Balance sheet total | € 138,423 | € 132,122 | € 162,825 | € 129,672 | ▼ 20% |
Key figures of PHARMACIE COUROUBLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE COUROUBLE?
What happened at PHARMACIE COUROUBLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 41,185 (▼ € 47,867 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Schaarbeek. KBO
- Nathalie Courouble became a director. NBB
- Dominique Courouble became a director. NBB
In short
From € 13,037 loss in 2022 to € 41,185 loss in 2025.
Paid € 1,401 in corporate taxes since 2022.
Best year ever: 2024, with € 6,682 profit.
A new publication or filing at PHARMACIE COUROUBLE? We notify you, reason included.
Follow PHARMACIE COUROUBLEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE COUROUBLE are Nathalie Courouble and Dominique Courouble.
Directors
According to the 2025 annual accounts
Nathalie Courouble
Director
since 2010
Dominique Courouble
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Koninginneplein 30
1030 Schaarbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
DIGITALOCEAN-ASN - DigitalOcean, LLC, US
DNS
OVH DNS
Website info
Features
Security
Details
- Company number
- 0828.815.213
- VAT number
- BE 0828.815.213
- Registered office
- Koninginneplein 30, 1030 Schaarbeek
- Names & denominations
- PHARMACIE COUROUBLE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 August 2010
- Peppol
- Active · Active since 20 Nov 2025
- Contact
- dynaphar.be
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Detailhandel in farmaceutische producten
Vervaardiging van gehomogeniseerde voedingspreparaten en dieetvoeding
Vervaardiging van overige farmaceutische producten
Vervaardiging van geneesmiddelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels